Management of Isolated Fever in Labour Compared with Clinical Chorioamnionitis in a Quaternary Centre

J Obstet Gynaecol Can. 2022 Jan;44(1):34-41. doi: 10.1016/j.jogc.2021.06.013.

Abstract

Objectives: To investigate treatment patterns of women with isolated fever in labour and evaluate if variables in the sepsis in obstetrics score (SOS) or fetal tachycardia are associated with treatment differences. Our secondary objective was to compare women with isolated fever in labour with women with clinical chorioamnionitis to identify any clinicodemographic differences.

Methods: A retrospective cohort study of 473 patients at BC Women's Hospital who presented with isolated fever in labour between January 2011 and April 2016 compared with a dataset of 1135 women with clinical chorioamnionitis from 2011 to 2016 in the same institution.

Results: In our cohort of isolated fever in labour, antibiotics were given 74.2 % of the time, and the majority received cefazolin and metronidazole (80.9%, of those who received antibiotics). Higher maternal temperature and heart rate at time of first fever and fetal tachycardia were associated with more antibiotic use. Slightly higher maternal temperature was associated with use of a saline bolus and blood cultures. The proportion of women with a SOS greater than 5 increased 4.5-fold from time of first fever to time of maximum SOS. There were fewer cesarean deliveries in the isolated fever in labour group compared with the clinical chorioamnionitis group (22.4% vs. 54.0%; P < 0.0001).

Conclusions: Slightly higher maternal temperature was associated with increased treatment, including antibiotic use, saline bolus administration, and blood cultures. As evidenced by the higher proportion of women with an SOS over 5, women with isolated fever in labour may have a propensity to deteriorate clinically.

Keywords: anti-bacterial agents; chorioamnionitis; fever; obstetrics; pregnancy.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cesarean Section
  • Chorioamnionitis* / drug therapy
  • Chorioamnionitis* / epidemiology
  • Female
  • Humans
  • Pregnancy
  • Retrospective Studies
  • Sepsis*

Substances

  • Anti-Bacterial Agents